Rare Insider

Casey McPherson: AlphaRose Therapeutics on doing things differently

By Nicola Miller

7 June 2025

Rare Insider

Are you aware of active clinical trials in your disease area?

By Joe Rumney

7 June 2025

Rare Insider

incognito: the secret life of a…healthcare communications CEO

By CONTRIBUTOR

7 June 2025

Rare Insider

Putting you in the heart of the rare community – Koolen-de Vries Syndrome Foundation

By CONTRIBUTOR

7 June 2025

Rare Insider

A new method of peptide synthesis may be the key to a greener future for pharma

By Shanzeh Mumtaz Ahmed

7 June 2025

Rare Insider

Jenny Ousbey of OVID Health

By CONTRIBUTOR

7 June 2025

Rare Insider

Dr Sara ten Have discusses the environmental impact of peptides in drug development

By Nicola Miller

7 June 2025

Rare Insider

Do you know where to find information on active clinical trials?

By Joe Rumney

7 June 2025

Rare Insider

Capturing real-world data: “the right data, at the right time, in the right way”

By Michelle Conway

7 June 2025

Rare Insider

The future of rare disease policy in England: what the DHSC takeover of NHS England means for patients and progress

By Henry Burkitt

7 June 2025

Rare Insider

“Our goal is to print a kidney in 24 hours”

By Julie Penfold

7 June 2025

Rare Insider

Jenifer Ngo Waldrop of Rare Disease Diversity Coalition (RDDC)

By CONTRIBUTOR

5 June 2025